Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netakimab in Active Ankylosing Spondylitis
NCT03447704Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of netakimab in ankylosing spondylitis (AS), sponsored by BIOCAD. Started Feb 2018; status: completed.
02
Drugs
netakimab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT03447704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447704.